Meanwhile, we compared the plasma ECHS1 protein levels in ACS patients with HF symptoms at New York Heart Association (NYHA) stage III or IV (n = 89) to those with HF symptoms at NYHA stage II or less (n = 61). The gene discussed is ECHS1; the disease is hydrops fetalis.